Rituximab and Belimumab for Lupus Nephritis

NCT02260934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

NIH

Sponsor class

Conditions

Lupus Nephritis

Interventions

BIOLOGICAL: Rituximab
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Methylprednisolone
DRUG: Diphenhydramine
DRUG: Acetaminophen
BIOLOGICAL: Rituximab
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Methylprednisolone
DRUG: Diphenhydramine
DRUG: Acetaminophen
BIOLOGICAL: Belimumab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]